Oncoinvent ASA (0RU5)
LSE
79.00
-1.80 (-2.23%)
Closed
Oct 6, 2026
Day's Range
79.0080.80
52 wk Range
0.4400141.50
Financial Statements - 0RU5 - Oncoinvent ASA
Revenue
599.85M▲ 115.0%
Net Income
59.39M▲ 175.6%Net Margin 9.9%
EBITDA
277.76M▲ 130.7%
Free Cash Flow
-5.15M▲ 75.4%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 599.85M | 278.96M | 257.18M | 263.29M |
| Cost of Goods | 394.37M | 168.74M | 172.60M | 166.72M |
| Gross Profit | 205.47M | 110.22M | 84.58M | 96.57M |
 Operating Expense | - | - | - | - |
| Operating Income | 158.44M | 74.24M | 52.08M | 68.95M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | -38.99M | -13.87M | -8.08M | -2.65M |
| Pre Tax Income | 107.18M | 58.95M | 43.97M | 67.34M |
| Income Tax | 47.78M | 37.40M | 20.17M | 33.35M |
| Net Income | 59.39M | 21.55M | 23.79M | 33.99M |
| EPS Basic | 0.24 | 0.12 | 0.15 | 0.21 |
| EPS Diluted | 0.23 | 0.12 | 0.14 | 0.21 |
| Basic Shares Outstanding | 237.99M | 174.99M | 160.19M | 159.78M |
| Diluted Shares Outstanding | 237.99M | 174.99M | 160.19M | 159.78M |
| Ebit | - | - | - | - |
| Ebitda | 277.76M | 120.42M | 99.28M | 116.66M |
| Net Income Continuous Operations | 59.39M | 21.55M | 23.79M | 33.99M |
| Minority Interests | -1.52M | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
